141 related articles for article (PubMed ID: 1565148)
1. The enteroinsular axis revisited. A novel role for an incretin.
Ensinck JW; D'Alessio DA
N Engl J Med; 1992 May; 326(20):1352-3. PubMed ID: 1565148
[No Abstract] [Full Text] [Related]
2. Enteroinsular signaling: perspectives on the role of the gastrointestinal hormones glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide in normal and abnormal glucose metabolism.
Vahl T; D'Alessio D
Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):461-8. PubMed ID: 12806222
[TBL] [Abstract][Full Text] [Related]
3. On the role of the incretin hormones GIP and GLP-1 in the pathogenesis of Type 2 diabetes mellitus.
Vilsbøll T
Dan Med Bull; 2004 Nov; 51(4):364-70. PubMed ID: 16009062
[No Abstract] [Full Text] [Related]
4. Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus.
Gutniak M; Orskov C; Holst JJ; Ahrén B; Efendic S
N Engl J Med; 1992 May; 326(20):1316-22. PubMed ID: 1348845
[TBL] [Abstract][Full Text] [Related]
5. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
[TBL] [Abstract][Full Text] [Related]
6. Possible role of the adrenergic mechanism in gastric inhibitory polypeptide- and glucagon-like peptide-1 (7-36) amide-induced insulin release in the rat.
Ikeda T; Ochi H; Ohtani I; Fujiyama K; Hoshino T; Tanaka Y; Takeuchi T; Mashiba H
Metabolism; 1993 Feb; 42(2):209-13. PubMed ID: 8386288
[TBL] [Abstract][Full Text] [Related]
7. [Gluco-incretin hormones in insulin secretion and diabetes].
Thorens B
Med Sci (Paris); 2003; 19(8-9):860-3. PubMed ID: 14593618
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 (7-37) augments insulin release in elderly patients with diabetes.
Meneilly GS; McIntosh CH; Pederson RA; Habener JF; Gingerich R; Egan JM; Elahi D
Diabetes Care; 2001 May; 24(5):964-5. PubMed ID: 11347771
[No Abstract] [Full Text] [Related]
9. Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.
Gault VA; O'Harte FP; Harriott P; Mooney MH; Green BD; Flatt PR
Diabetologia; 2003 Feb; 46(2):222-30. PubMed ID: 12627321
[TBL] [Abstract][Full Text] [Related]
10. New developments in the incretin concept.
Creutzfeldt W; Ebert R
Diabetologia; 1985 Aug; 28(8):565-73. PubMed ID: 3902545
[TBL] [Abstract][Full Text] [Related]
11. [Digestive tract hormones and pancreatic secretion].
Shima K
Nihon Naibunpi Gakkai Zasshi; 1990 Dec; 66(12):1228-35. PubMed ID: 2292313
[No Abstract] [Full Text] [Related]
12. Entero-insular axis and diabetes mellitus.
Creutzfeldt W
Horm Metab Res Suppl; 1992; 26():13-8. PubMed ID: 1490680
[TBL] [Abstract][Full Text] [Related]
13. Overview of incretin hormones.
Efendic S; Portwood N
Horm Metab Res; 2004; 36(11-12):742-6. PubMed ID: 15655702
[TBL] [Abstract][Full Text] [Related]
14. [Review: regulation of glucose metabolism].
Yamada Y; Seino Y
Nihon Rinsho; 2002 Jul; 60 Suppl 7():153-8. PubMed ID: 12238041
[No Abstract] [Full Text] [Related]
15. Gastric inhibitory polypeptide analogues: do they have a therapeutic role in diabetes mellitus similar to that of glucagon-like Peptide-1?
Holst JJ
BioDrugs; 2002; 16(3):175-81. PubMed ID: 12102645
[TBL] [Abstract][Full Text] [Related]
16. The ageing entero-insular axis.
Ranganath L; Sedgwick I; Morgan L; Wright J; Marks V
Diabetologia; 1998 Nov; 41(11):1309-13. PubMed ID: 9833938
[TBL] [Abstract][Full Text] [Related]
17. Incretin hormones--an update.
Holst JJ; Orskov C
Scand J Clin Lab Invest Suppl; 2001; 234():75-85. PubMed ID: 11713984
[TBL] [Abstract][Full Text] [Related]
18. GIP, incretin and gastrointestinal disease.
Lauritsen KB
Dan Med Bull; 1983 Jun; 30(4):205-14. PubMed ID: 6347538
[No Abstract] [Full Text] [Related]
19. Incretin hormones and insulin secretion.
Ahrén B; Gromada J; Schmitz O
Horm Metab Res; 2004; 36(11-12):733-4. PubMed ID: 15655700
[No Abstract] [Full Text] [Related]
20. Effect of lipase inhibition on gastric emptying of, and the glycemic and incretin responses to, an oil/aqueous drink in type 2 diabetes mellitus.
Pilichiewicz A; O'Donovan D; Feinle C; Lei Y; Wishart JM; Bryant L; Meyer JH; Horowitz M; Jones KL
J Clin Endocrinol Metab; 2003 Aug; 88(8):3829-34. PubMed ID: 12915676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
